Stanley Laman Group Ltd. Has $326,000 Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Stanley Laman Group Ltd. boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.4% during the 4th quarter, Holdings Channel reports. The institutional investor owned 625 shares of the medical equipment provider’s stock after purchasing an additional 74 shares during the quarter. Stanley Laman Group Ltd.’s holdings in Intuitive Surgical were worth $326,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of ISRG. Berbice Capital Management LLC acquired a new position in Intuitive Surgical during the 4th quarter worth $26,000. Godsey & Gibb Inc. lifted its holdings in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. acquired a new position in Intuitive Surgical during the 3rd quarter worth $33,000. Decker Retirement Planning Inc. acquired a new position in Intuitive Surgical during the 4th quarter worth $36,000. Finally, Capital Performance Advisors LLP acquired a new position in Intuitive Surgical during the 3rd quarter worth $38,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity

In other news, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,967,734. This trade represents a 6.39 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,746,819.42. The trade was a 1.22 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 6,348 shares of company stock worth $3,587,582 in the last quarter. Corporate insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on ISRG shares. Evercore ISI increased their price target on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Barclays increased their price target on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Jefferies Financial Group increased their price target on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Piper Sandler reissued an “overweight” rating and issued a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Finally, Stifel Nicolaus increased their price target on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Trading Up 0.3 %

ISRG stock opened at $591.39 on Friday. The stock has a 50-day moving average price of $557.70 and a two-hundred day moving average price of $517.49. The stock has a market cap of $210.64 billion, a PE ratio of 92.26, a price-to-earnings-growth ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.